Beta Cat Pharmaceuticals, Inc. — Form D

Beta Cat Pharmaceuticals, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-27. The offering totals $6.0M, of which $2.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Kenneth CarterDirectorSAN FRANCISCO, CA
Joe CunninghamDirectorAUSTIN, TX
James EadieDirectorArden Hills, MN
Jonathan NorthrupDirectorHouston, TX
Rahul ArasExecutive OfficerCleveland, OH
Uma BhattExecutive OfficerHouston, TX
Sunil P SharmaDirectorDallas, TX
Sunil P SharmaExecutive OfficerDallas, TX
Sunil SharmaDirectorVancouver, A1
Sunil SharmaExecutive OfficerVancouver, A1
Joseph CunninghamDirectorSunrise, FL
Kenneth C CarterDirectorSYKESVILLE, MD
Scott JordanDirectorSandy, UT
Scott JordanExecutive OfficerSandy, UT
Jonathan NorthrupExecutive OfficerHouston, TX
Kenneth P CarterDirectorHouston, TX
Joseph P CunninghamDirectorHouston, TX
Alain P CappelutiExecutive OfficerHouston, TX
Stephen P HorriganExecutive OfficerHouston, TX
Casey P CunninghamExecutive OfficerHouston, TX
Alain C CappelutiExecutive OfficerGaithersburg, MD
Sunil C SharmaDirectorGaithersburg, MD
Sunil C SharmaExecutive OfficerGaithersburg, MD
Jonathan P NorthrupDirectorGaithersburg, MD
Jonathan P NorthrupExecutive OfficerGaithersburg, MD

Other filings by this issuer (3)

FiledFormOfferingSold
2017-12-18D$1.4M$1.4M
2015-07-02D$3.0M$1.0M
2014-07-08D$500K$500K

More